Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma

Summary Mantle cell lymphoma (MCL) is an aggressive form of non‐Hodgkin lymphoma that remains incurable for the majority of patients. Allogeneic stem cell transplantation (alloSCT) produces long‐term disease‐free remissions for around 30–40% patients, however it is reserved for the treatment of rela...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2019-03, Vol.184 (6), p.999-1005
Hauptverfasser:	Rule, Simon, Cook, Gordon, Russell, Nigel H., Hunter, Ann, Robinson, Stephen, Morley, Nick, Sureda, Anna, Patrick, Pip, Clifton‐Hadley, Laura, Adedayo, Toyin, Kirkwood, Amy, Peggs, Karl S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged clinical trials Cytarabine Etoposide Female Graft-versus-host reaction Hematology Hematopoietic Stem Cell Transplantation - methods Humans Induction therapy Lymphoma Lymphoma, Mantle-Cell - pathology Lymphoma, Mantle-Cell - therapy Lymphoma, Non-Hodgkin - pathology Lymphoma, Non-Hodgkin - therapy Male Mantle cell lymphoma Medical treatment Melphalan Middle Aged non‐Hodgkin lymphoma Patients Remission Stem cell transplantation Stem cells Transplantation Transplantation Conditioning - methods Transplantation, Homologous - methods Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!